Forrest E. Gaul

590 total citations
8 papers, 502 citations indexed

About

Forrest E. Gaul is a scholar working on Radiology, Nuclear Medicine and Imaging, Pulmonary and Respiratory Medicine and Surgery. According to data from OpenAlex, Forrest E. Gaul has authored 8 papers receiving a total of 502 indexed citations (citations by other indexed papers that have themselves been cited), including 5 papers in Radiology, Nuclear Medicine and Imaging, 4 papers in Pulmonary and Respiratory Medicine and 1 paper in Surgery. Recurrent topics in Forrest E. Gaul's work include Radiopharmaceutical Chemistry and Applications (5 papers), Medical Imaging and Pathology Studies (4 papers) and Monoclonal and Polyclonal Antibodies Research (3 papers). Forrest E. Gaul is often cited by papers focused on Radiopharmaceutical Chemistry and Applications (5 papers), Medical Imaging and Pathology Studies (4 papers) and Monoclonal and Polyclonal Antibodies Research (3 papers). Forrest E. Gaul collaborates with scholars based in United States. Forrest E. Gaul's co-authors include David A. Schwartz, Matthew J. Abrams, Malik E. Juweid, R H Rubin, H. William Strausś, Alan J. Fischman, Michael J. Abrams, Scott K. Larsen, Jon Zubieta and Gary Bridger and has published in prestigious journals such as Journal of Medicinal Chemistry, Bioconjugate Chemistry and Journal of Natural Products.

In The Last Decade

Forrest E. Gaul

8 papers receiving 485 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Forrest E. Gaul United States 8 303 163 157 87 70 8 502
Elisabeth Miot‐Noirault France 14 194 0.6× 191 1.2× 120 0.8× 76 0.9× 42 0.6× 31 469
Alain Gast Switzerland 11 52 0.2× 258 1.6× 117 0.7× 63 0.7× 50 0.7× 19 558
Marlein Miranda Cona Belgium 13 202 0.7× 205 1.3× 133 0.8× 96 1.1× 22 0.3× 33 542
Jingli Xu United States 14 213 0.7× 146 0.9× 113 0.7× 67 0.8× 16 0.2× 33 430
Eric Sousa United States 8 130 0.4× 237 1.5× 108 0.7× 68 0.8× 9 0.1× 9 436
K Hasumi Japan 13 138 0.5× 122 0.7× 97 0.6× 53 0.6× 101 1.4× 49 531
Babak Nami Canada 12 124 0.4× 231 1.4× 246 1.6× 53 0.6× 24 0.3× 17 530
Pia Ek Sweden 14 61 0.2× 477 2.9× 87 0.6× 55 0.6× 45 0.6× 28 663
G. R. Boniface Australia 10 158 0.5× 182 1.1× 239 1.5× 60 0.7× 43 0.6× 23 476
Hironori Kikkawa Japan 12 75 0.2× 226 1.4× 127 0.8× 53 0.6× 11 0.2× 23 418

Countries citing papers authored by Forrest E. Gaul

Since Specialization
Citations

This map shows the geographic impact of Forrest E. Gaul's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Forrest E. Gaul with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Forrest E. Gaul more than expected).

Fields of papers citing papers by Forrest E. Gaul

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Forrest E. Gaul. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Forrest E. Gaul. The network helps show where Forrest E. Gaul may publish in the future.

Co-authorship network of co-authors of Forrest E. Gaul

This figure shows the co-authorship network connecting the top 25 collaborators of Forrest E. Gaul. A scholar is included among the top collaborators of Forrest E. Gaul based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Forrest E. Gaul. Forrest E. Gaul is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

8 of 8 papers shown
1.
Gaul, Forrest E., et al.. (2000). Determination of loperamide in rat plasma and bovine serum albumin by LC. Journal of Pharmaceutical and Biomedical Analysis. 22(3). 555–561. 23 indexed citations
2.
Bridger, Gary, Michael J. Abrams, Clifford Longley, et al.. (1997). Tumor imaging with technetium-99m-labeled hydrazinonicotinamide-Fab' conjugates.. PubMed. 38(1). 133–8. 24 indexed citations
3.
Bridger, Gary, Michael J. Abrams, Sreenivasan Padmanabhan, et al.. (1996). A Comparison of Cleavable and Noncleavable Hydrazinopyridine Linkers for the99mTc Labeling of Fab‘ Monoclonal Antibody Fragments. Bioconjugate Chemistry. 7(2). 255–264. 22 indexed citations
4.
Higgins, John, Gary Bridger, Claudia K. Derian, et al.. (1996). N-Terminus Urea-Substituted Chemotactic Peptides:  New Potent Agonists and Antagonists toward the Neutrophil fMLF Receptor. Journal of Medicinal Chemistry. 39(5). 1013–1015. 42 indexed citations
5.
Knight, Linda, et al.. (1992). Preparation and preliminary evaluation of technetium-99m-labeled fragment E1 for thrombus imaging.. PubMed. 33(5). 710–5. 7 indexed citations
6.
Bentley, Michael D., Forrest E. Gaul, Mohamed S. Rajab, & Ahmed Hassanali. (1992). Tetranortriterpenes from Turraea robusta. Journal of Natural Products. 55(1). 84–87. 13 indexed citations
7.
Schwartz, David A., et al.. (1991). Preparation of hydrazino-modified proteins and their use for the synthesis of technetium-99m-protein conjugates. Bioconjugate Chemistry. 2(5). 333–336. 71 indexed citations
8.
Abrams, Matthew J., Malik E. Juweid, David A. Schwartz, et al.. (1990). Technetium-99m-human polyclonal IgG radiolabeled via the hydrazino nicotinamide derivative for imaging focal sites of infection in rats.. PubMed. 31(12). 2022–8. 300 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026